Mary is an energetic and passionate leader with twenty five years of experience in the clinical trial research industry. Now a founding partner at Harpula, where she is looking to foster the growth of next-generation clinical trial technology, her clinical research path was built through multi-national CROs. In these roles, she was responsible for execution of operational, technology and regulatory requirements for Phase I-IV trials. As the Chief Operating Officer at Synteract, Mary contributed to the growth and success of the company through process improvement, team development, and customer delivery resulting in double digit revenue and profitability growth and a successful 4X sale to Syneos Health.Mary's passion is working with people to attain lofty goals, and she has loved defining and managing teams from 20 to 500 people to achieve deliverables as well as quality, revenue, and profitability targets. Mary's broad-based skills in identification and implementation of clinical technology solutions have developed by identifying and implementing solutions for CRO and SMO needs in growth environments. Mary has shown proven leadership in organizational change, team development, and process creation as well as defining and developing global teams to meet the demands of today’s clinical research environment.